2021 Cornea and Eye Banking Forum

The Cornea and Eye Banking Forum, hosted by the Eye Bank Association of America and the Cornea Society , was held and recorded on Friday, November 12. The program, available on-demand, highlights the latest scientific and research developments in cornea and eye banking and innovations that are on the horizon.

The online program features:

• Invited Panel Discussions:
  • Future of the Treatment of Corneal Endothelial and Stromal Disease
  • Future of Artificial Cornea
• The R. Townley Paton Award Lecture delivered by the 2021 Paton Award Recipient, Jennifer Li, MD:
  • Well-Behaved Women Seldom Make History: A Look at the Progress of Women in Ophthalmology
• The Troutman Prize Lecture presented by the 2021 Troutman Prize Recipient, Maria A. Henriquez, MD, PhD
  • Accelerated Epi-On Versus Standard Epi-Off Corneal Collagen Cross-Linking for Progressive Keratoconus in Pediatric Patients: Five Years of Follow-Up
• Presentation of Scientific Abstracts followed by dynamic Q&A sessions

Access the 2021 Cornea and Eye Banking Forum for FREE! No CEUs awarded.

AWARD LECTURES
R. Townley Paton Lecture: Well-Behaved Women Seldom Make History: The Advancement of Women in Ophthalmology
Jennifer Li, MD, 2021 R. Townley Paton Award Recipient 

Richard Troutman Prize Lecture: Accelerated Epi-On Versus Standard Epi-Off Corneal Collagen Cross-Linking for Progressive Keratoconus in Pediatric Patients: Five Years of Follow-Up
Maria A. Henriquez, MD, MSc, PhD, Oftalmosalud Instituto de Ojos 

SECTION I

INVITED SESSION: Future of the Treatment of Corneal Endothelial and Stromal Disease
Presenters:
Jorge Alió, MD, PhD, FEBO, University Miguel Hernández of Elche
Kathryn Colby, MD, PhD, NYU Langone Health
Ula Jurkunas, MD, Mass Eye and Ear
Jodhbir Mehta, MBBS, FRCOphth, FRCS(Ed), FAMS, PhD, Singapore National Eye Centre

Topical Ivmed-80 Eyedrops for Pharmacologic Crosslinking of Keratoconus without UV Light or Surgery
Balamurali Ambati, MD, PhD, Pacific Clear Vision Institute 

Nicergoline: A Potential Novel Treatment for Severe Persistent Corneal Epithelial Defects
Valeria Oliva-Biénzobas, MD, Centro de la Vision

Topical 1% 5-fluorouracil as Primary Treatment for Ocular Surface Squamous Neoplasia: Long-Term Follow-up Study
Adam Wylegala, MD, DMS, FEBO, Bascom Palmer Eye Institute 

Phlyctenular Disease Associated with Increased Incidence and Severe Corneal Sequelae in Hispanic Pediatric Patients
Aaron R. Kaufman, MD, University of Illinois at Chicago, Illinois Eye and Ear Infirmary 

Outcomes of Fluid-Filled Scleral Lens Devices for the Management of Limbal Stem Cell Deficiency
Clémence Bonnet, MD, Stein Eye Institute, UCLA

SECTION II

Effect of Increasing Povidone Iodine (PVP-I) Exposure on Tissue Quality and Impact on Donor Rim Cultures
Onkar Sawant, PhD, Eversight

Double Povidone Iodine Wash: Effectivity in Reducing the Infection Rate of Recovered Corneal Tissue
Stephen C. Kaufman, MD, PhD, University of Minnesota

Induction of Antimicrobial Peptide Expression in Human Donor Corneas Using Andrographolide
Madeline Yung, MD, University of California, Davis 

The Impact of Amphotericin B Fortified Preservation Media on Rates of Endothelial Keratoplasty Detachment
Vincent Hussey, MS, University of California, Irvine 

Endophthalmitis Rates Following Cornea Surgery in the Medicare Population from 2016 to 2019
Fasika Woreta, MD, MPH, Wilmer Eye Institute 

The Microbiome in Stevens-Johnson Syndrome
Michael Zilliox, PhD, Loyola University Chicago 

SECTION III

Descemet Membrane Endothelial Keratoplasty (DMEK): 10-year Clinical Outcomes and Graft Survival
Viridiana Kocaba, MD, PhD, FEBO, Netherlands Institute for Innovative Ocular Surgery (NIIOS) 

Two Year Changes in Corneal Power after Endothelial Keratoplasty: Results from the Randomized Controlled DETECT Trial
Winston Chamberlain, MD, PhD, Oregon Health & Science University
Note: Due to technical difficulties, only half of this presentation has been recorded and made available. 

Primary Graft Failure Following Descemet Membrane Endothelial Keratoplasty Using Nondiabetic Donor Tissue
Andrea Blitzer, MD, University of Iowa 

Does the Size and Duration of the Bubble in DMEK Surgery Affect the Attachment and Endothelial Cell Loss of the DMEK Graft?
Jessica Chen, MD, Devers Eye Institute 

Comparison of Graft Viability in Tri-Folded Endothelium-In and Scrolled Endothelium-Out Preloaded Descemet Membrane Endothelial Keratoplasty
Matthew Hartman, MD, Southeast Eye Specialists 

Difference in Postoperative Graft Adherence Between Descemet Membrane Endothelial Keratoplasty with and without Cataract Surgery
Anne-Marie Kladny, MD, University of Freiburg 

Novel Preloaded Injectable UT-Descemet’s Stripping Automated Endothelial Keratoplasty (UT-DSAEK): No Touch Surgical Technique and Early Surgical Results
Steven Kane, MD, Tailored Eyes 

An Alternative Time Efficient Method to Specular Microscopy Following DMEK Preparation Using Trypan Blue Staining
Michael Szkarlat, BS, Eversight 

Section IV

INVITED SESSION: Future of Artificial Cornea
Presenters:
Esen Akpek, MD, Johns Hopkins University
Julie Daniels, PhD, University College London
Anthony Aldave, MD, Stein Eye Institute, UCLA 

Regulatory T-cells Promote Corneal Graft Survival by Modulating PostTransplantation Alloimmune Response
Hamid Alemi, MD, MPH, Schepens Eye Research Institute/ Massachusetts Eye and Ear

Association Between Anti-Human Leukocyte Antigen (HLA) Antibodies and Graft Rejection in Pediatric Keratoplasty
Angela Zhu, MD, Bascom Palmer Eye Institute, University of Miami 

Hyaluronic-Acid Based Bioengineered Corneal Stromal Substitute
Roza Vaez Ghaemi, PhD, University of British Columbia 

Prospective, Randomized, Multicenter, Double-Masked, Clinical Trial Evaluating Corneal Crosslinking of Keratoprosthesis Carrier Tissue
Joseph B. Ciolino, MD, Schepens Eye Institute/ Mass Eye and Ear 

ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Cornea Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS
Amedco LLC designates this live activity for a maximum of 7.5 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

CEBTS
Eye Bank Association of America approves this activity for a maximum of 7 CEUs. The CEUs will be transferred to your EBAA account once all of the sessions are completed. Partial credit will not be given. 

OBJECTIVES

1. Learn new developments, techniques and therapies in sight restoration.

2. Analyze the efficacy of emerging technologies and innovative processes in corneal transplantation and eye banking that can improve patient outcomes.

3. Cite new research findings in cornea regarding disease, treatment, transplantation, preservation, preparation and processing.

CME CREDIT CLAIM

CME Evaluation

SUPPORT
Thank you to the following companies for their generous support through unrestricted educational grants. 

Best Paper of Session Award
Lions Gift of Sight

General Support
Wolters Kluwer
Med-Logics, LLC